Skip to main content
Clinical Trials/CTRI/2025/08/093057
CTRI/2025/08/093057Not yet recruitingPhase 2/3

Randomised controlled clinical trial to compare the efficacy of Bilwa Magaja Choorna with Nagakeshar Choorna in the management of Raktarsha

Tilak Ayurved Mahavidyalaya Pune1 site in 1 country70 target enrollmentStarted: August 25, 2025Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
70
Locations
1
Primary Endpoint
The use of Bilwa Magaja Choorna with Nagkeshar Choorna was effective in reducing Rakta Strava in Raktaarsha.

Study Overview

Brief Summary

Objective

To evaluate and compare the clinical efficacy of Bilwa Magaja Choorna and Nagkeshar Choorna in treating Raktarsha (bleeding haemorrhoids), and to assess potential adverse effects

Background

Raktarsha, a form of Arsha (haemorrhoids), is a common anorectal disorder in Ayurveda, linked to poor diet, sedentary lifestyle, and Agnimandya (impaired digestion).

Modern surgical treatments often have complications; hence, the study seeks safer, cost-effective, Ayurvedic alternatives.

Hypothesis

Null Hypothesis Bilwa Magaja Choorna is as effective as Nagkeshar Choorna.

Alternative Hypothesis  Bilwa Magaja Choorna is more effective.

Methodology

Design: Open-label, randomized controlled clinical trial.

Participants: 70 patients (35 in each group) with 1st and 2nd degree Raktarsha.

Intervention

Group A (Trial): Bilwa Magaja Choorna (12 gm) with warm water.

Group B (Control): Nagkeshar Choorna (12 gm) with Navneet and Khadisakhar.

Duration: 14 days with follow-ups on Day 7 and Day 14.

Common Supportive Drug: Gandharva Haritaki Choorna (laxative).

Assessment Parameters

Subjective: Quantity of bleeding per anus.

Objective: Frequency of bleeding.

Investigations: Hb%, HIV, HBsAg.

Inclusion Criteria:

Age 18–60 years, 1st/2nd degree Raktarsha, Hb  less than 8 gm%.

Exclusion Criteria

3rd/4th degree haemorrhoids, Hb <8 gm%, pregnancy, HIV/HBsAg positive.

Analysis Tools:

Statistical Tests: Wilcoxon signed-rank test (subjective), t-test (objective).

Knowledge Gap & Rationale:

No prior comparative study on Bilwa Magaja Choorna alone.

Expected to be cost-effective, safe, and easy to administer.

Conclusion:

The study aims to establish Bilwa Magaja Choorna as a potentially more effective Ayurvedic treatment for Raktarsha compared to the standard Nagkeshar Choorna.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Patients having Raktarsha (1st degree,2nd degree) will be selected.
  • 2.Patient with Hb less than 8gm% 3.Patient of age between 18-60 years will be taken.
  • 4.Selected of patient will be done irrespective of sex, socioeconomic class, religion.

Exclusion Criteria

  • 1.Known case of 3rd and 4th degree haemorrhoids 3rd Degree haemorrhoids- Piles prolapsed during defecation, can be replaced back only by manual help.
  • 4th Degree haemorrhoids- piles that are permanently prolapsed
  • Patients with Hb more than 8 gm%
  • Pregnancy
  • Known case of HIV, HBsAg excluded.

Outcomes

Primary Outcomes

The use of Bilwa Magaja Choorna with Nagkeshar Choorna was effective in reducing Rakta Strava in Raktaarsha.

Time Frame: 1st follow up on 7th day and then on 14th day

Secondary Outcomes

  • Adverse drug reaction observed during treatment of Raktarsha with Bilwa magaja choorna(1st follow up on 7th day and then on 14th day)

Investigators

Sponsor
Tilak Ayurved Mahavidyalaya Pune
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr Shrikant Balaji Bhosale

Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurvedic Hospital

Study Sites (1)

Loading locations...

Similar Trials